Effects of low doses of the novel dehydroepiandrosterone (DHEA) derivative BNN27 in rat models of anxiety

Psychopharmacology (Berl). 2024 Feb;241(2):341-350. doi: 10.1007/s00213-023-06490-9. Epub 2023 Nov 2.

Abstract

Rationale: Several lines of evidence indicate that the neurosteroid dehydroepiandrosterone (DHEA) is involved in anxiety. BNN27 is a new DHEA derivative lacking steroidogenic effects. The beneficial effects exerted by BNN27 in preclinical models of schizophrenia and memory disorders have been recently reported.

Objectives: The present study was designed to investigate the effects of this DHEA novel analog on anxiety-like behavior in rats.

Methods: To this end, the light/dark box, the open field, the contextual fear conditioning, and the excessive self-grooming induced by the serotonin 5-HT2c receptor agonist mCPP tests were utilized.

Results: Animals treated acutely with BNN27 (1, 3, and 6 mg/kg) dose dependently spent more time in the bright compartment of the light/dark box and in the central zone of the open field with respect to their vehicle-treated cohorts. Further, BNN27 reduced freezing behavior and weakened the mCPP-induced excessive self-grooming.

Conclusions: Our data indicate that BNN27 is a highly potent anxiolytic agent, as in all studied paradigms it showed anxiolytic-like effects in male rats.

Keywords: Anxiety; BNN27; DHEA; Rat.

MeSH terms

  • Animals
  • Anti-Anxiety Agents* / pharmacology
  • Anti-Anxiety Agents* / therapeutic use
  • Anxiety Disorders / drug therapy
  • Anxiety* / drug therapy
  • Dehydroepiandrosterone / pharmacology
  • Male
  • Rats

Substances

  • Anti-Anxiety Agents
  • Dehydroepiandrosterone